Sen. Kennedy’s Foreign Inspection Bill Gives FDA More Flexibility Than House

House and Senate Democrats are taking similar approaches to invigorate FDA's ability to oversee foreign manufacturing facilities. Some fundamental differences and Republican concerns, however, suggest the issue will likely not be resolved until at least the next Congress

More from Archive

More from Pink Sheet